{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:28:50Z","timestamp":1721867330643},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s00108-024-01745-9","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T17:01:56Z","timestamp":1721062916000},"page":"762-769","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antiarrhythmika in der heutigen Zeit","Antiarrhythmic drugs in the present day"],"prefix":"10.1007","volume":"65","author":[{"given":"R.","family":"Allgaier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Duncker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,15]]},"reference":[{"issue":"8","key":"1745_CR1","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","volume":"143","author":"SS Virani","year":"2021","unstructured":"Virani\u00a0SS, Alonso\u00a0A, Aparicio\u00a0HJ, Benjamin\u00a0EJ, Bittencourt\u00a0MS, Callaway\u00a0CW et\u00a0al (2021) Heart Disease and Stroke Statistics\u20142021 Update: A\u00a0Report From the American Heart Association. Circulation 143(8):e254\u2013e743","journal-title":"Circulation"},{"issue":"5","key":"1745_CR2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks\u00a0G, Potpara\u00a0T, Dagres\u00a0N, Arbelo\u00a0E, Bax\u00a0JJ, Blomstr\u00f6m-Lundqvist\u00a0C et\u00a0al (2021) 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart\u00a0J 42(5):373\u2013498","journal-title":"Eur Heart J"},{"key":"1745_CR3","first-page":"732an","volume":"20(5):731","author":"G-A Dan","year":"2018","unstructured":"Dan\u00a0G\u2011A, Martinez-Rubio\u00a0A, Agewall\u00a0S, Boriani\u00a0G, Borggrefe\u00a0M, Gaita\u00a0F et\u00a0al (2018) Antiarrhythmic drugs\u2014clinical use and clinical decision making: a\u00a0consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP). Europace 20(5):731:732an","journal-title":"Europace"},{"key":"1745_CR4","doi-asserted-by":"crossref","unstructured":"Svennberg E, Tjong F, Goette A, Akoum N, Di BL, Bordachar P et al (2022) How to use digital devices to detect and manage arrhythmias: an EHRA practical guide. Europace 2022 Jul 15;24(6):979-1005. doi: 10.1093\/europace\/euac038 (https:\/\/pubmed.ncbi.nlm.nih.gov\/35368065\/)","DOI":"10.1093\/europace\/euac067"},{"key":"1745_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/europace\/euad176","volume":"25","author":"E Svennberg","year":"2023","unstructured":"Svennberg\u00a0E, Caiani\u00a0EG, Bruining\u00a0N, Desteghe\u00a0L, Han\u00a0JK, Narayan\u00a0SM et\u00a0al (2023) The digital journey: 25\u00a0years of digital development in electrophysiology from an Europace perspective. Europace 25:8:euad176","journal-title":"Europace"},{"key":"1745_CR6","doi-asserted-by":"crossref","unstructured":"Hillmann HAK, Soltani S, Mueller-Leisse J, Hohmann S, Duncker D (2022) Cardiac rhythm monitoring using wearables for clinical guidance before and after catheter ablation. J Clin Med 11(9):2428","DOI":"10.3390\/jcm11092428"},{"issue":"1","key":"1745_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1177\/1933719115615878","volume":"29","author":"MH Parker","year":"2016","unstructured":"Parker\u00a0MH, Sanoski\u00a0CA (2016) Clinical pearls in using antiarrhythmic drugs in the outpatient setting. J\u00a0Pharm Pract 29(1):77\u201386","journal-title":"J Pharm Pract"},{"issue":"1","key":"1745_CR8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1093\/europace\/euac062","volume":"25","author":"RB Schnabel","year":"2023","unstructured":"Schnabel\u00a0RB, Marinelli\u00a0EA, Arbelo\u00a0E, Boriani\u00a0G, Boveda\u00a0S, Buckley\u00a0CM et\u00a0al (2023) Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th\u00a0AFNET\/EHRA consensus conference. Europace 25(1):6\u201327","journal-title":"Europace"},{"issue":"14","key":"1745_CR9","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","volume":"383","author":"P Kirchhof","year":"2020","unstructured":"Kirchhof\u00a0P, Camm\u00a0AJ, Goette\u00a0A, Brandes\u00a0A, Eckardt\u00a0L, Elvan\u00a0A et\u00a0al (2020) Early rhythm-control therapy in patients with atrial fibrillation. N\u00a0Engl J Med 383(14):1305\u20131316","journal-title":"N Engl J Med"},{"issue":"6","key":"1745_CR10","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1056\/NEJM198908103210629","volume":"321","author":"-","year":"1989","unstructured":"- (1989) Preliminary report: effect of encainide and flecainide on mortality in a\u00a0randomized trial of arrhythmia suppression after myocardial infarction. N\u00a0Engl J Med 321(6):406\u2013412","journal-title":"N Engl J Med"},{"key":"1745_CR11","doi-asserted-by":"publisher","first-page":"104443","DOI":"10.1016\/j.phrs.2019.104443","volume":"148","author":"E Paolini","year":"2019","unstructured":"Paolini\u00a0E, Stronati\u00a0G, Guerra\u00a0F, Capucci\u00a0A (2019) Flecainide: electrophysiological properties, clinical indications, and practical aspects. Pharmacol Res 148:104443","journal-title":"Pharmacol Res"},{"key":"1745_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.amjcard.2020.10.063","volume":"140","author":"JA Reiffel","year":"2021","unstructured":"Reiffel\u00a0JA, Capucci\u00a0A (2021) \u201cPill in the Pocket\u201d Antiarrhythmic Drugs for Orally Administered Pharmacologic Cardioversion of Atrial Fibrillation. Am J Cardiol 140:55\u201361","journal-title":"Am J Cardiol"},{"issue":"40","key":"1745_CR13","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","volume":"43","author":"K Zeppenfeld","year":"2022","unstructured":"Zeppenfeld\u00a0K, Tfelt-Hansen\u00a0J, de Riva\u00a0M, Winkel\u00a0BG, Behr\u00a0ER, Blom\u00a0NA et\u00a0al (2022) 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart\u00a0J 43(40):3997\u20134126","journal-title":"Eur Heart J"},{"issue":"6","key":"1745_CR14","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s40256-020-00401-5","volume":"20","author":"D Hamilton","year":"2020","unstructured":"Hamilton\u00a0D, Nandkeolyar\u00a0S, Lan\u00a0H, Desai\u00a0P, Evans\u00a0J, Hauschild\u00a0C et\u00a0al (2020) Amiodarone: a\u00a0comprehensive guide for clinicians. Am J Cardiovasc Drugs 20(6):549\u2013558","journal-title":"Am J Cardiovasc Drugs"},{"issue":"13","key":"1745_CR15","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1001\/jama.2019.0693","volume":"321","author":"DL Packer","year":"2019","unstructured":"Packer\u00a0DL, Mark\u00a0DB, Robb\u00a0RA, Monahan\u00a0KH, Bahnson\u00a0TD, Poole\u00a0JE et\u00a0al (2019) Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial. JAMA 321(13):1261\u20131274","journal-title":"JAMA"},{"issue":"4","key":"1745_CR16","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJMoa2029980","volume":"384","author":"JG Andrade","year":"2021","unstructured":"Andrade\u00a0JG, Wells\u00a0GA, Deyell\u00a0MW, Bennett\u00a0M, Essebag\u00a0V, Champagne\u00a0J et\u00a0al (2021) Cryoablation or drug therapy for initial treatment of atrial fibrillation. N\u00a0Engl J Med 384(4):305\u2013315","journal-title":"N Engl J Med"},{"issue":"5","key":"1745_CR17","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/eurheartj\/ehz467","volume":"41","author":"J Brugada","year":"2020","unstructured":"Brugada\u00a0J, Katritsis\u00a0DG, Arbelo\u00a0E, Arribas\u00a0F, Bax\u00a0JJ, Blomstr\u00f6m-Lundqvist\u00a0C et\u00a0al (2020) 2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe task force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). Eur Heart\u00a0J 41(5):655\u2013720","journal-title":"Eur Heart J"},{"issue":"5","key":"1745_CR18","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.jelectrocard.2018.06.007","volume":"51","author":"Y Michowitz","year":"2018","unstructured":"Michowitz\u00a0Y, Belhassen\u00a0B (2018) New Insights on Verapamil-Sensitive Idiopathic Left Fascicular Tachycardia. J\u00a0Electrocardiol 51(5):874\u2013878","journal-title":"J Electrocardiol"},{"issue":"1","key":"1745_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s12181-022-00585-x","volume":"17","author":"J Bauersachs","year":"2023","unstructured":"Bauersachs\u00a0J, Maier\u00a0L, ter Horst\u00a0N, Bavendiek\u00a0U (2023) Lieferengpass Digitoxin. Kardiologie 17(1):39\u201342","journal-title":"Kardiologie"},{"issue":"8","key":"1745_CR20","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1007\/s00392-023-02199-z","volume":"112","author":"U Bavendiek","year":"2023","unstructured":"Bavendiek\u00a0U, Gro\u00dfhennig\u00a0A, Schwab\u00a0J, Berliner\u00a0D, Liu\u00a0X, Maier\u00a0L et\u00a0al (2023) Simple and safe digitoxin dosing in heart failure based on data from the DIGIT-HF trial. Clin Res Cardiol 112(8):1096\u20131107","journal-title":"Clin Res Cardiol"},{"key":"1745_CR21","doi-asserted-by":"publisher","first-page":"103400","DOI":"10.1016\/j.etap.2020.103400","volume":"79","author":"J Patocka","year":"2020","unstructured":"Patocka\u00a0J, Nepovimova\u00a0E, Wu\u00a0W, Digoxin\u00a0KK (2020) Pharmacology and toxicology\u2014a review. Environ Toxicol Pharmacol 79:103400","journal-title":"Environ Toxicol Pharmacol"},{"issue":"7588","key":"1745_CR22","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1136\/bmj.39090.709537.47","volume":"334","author":"WSA Smellie","year":"2007","unstructured":"Smellie\u00a0WSA, Coleman\u00a0JJ (2007) Pitfalls of testing and summary of guidance on safety monitoring with amiodarone and digoxin. BMJ 334(7588):312\u2013315","journal-title":"BMJ"},{"issue":"5","key":"1745_CR23","doi-asserted-by":"publisher","first-page":"e007955","DOI":"10.1161\/CIRCEP.121.007955","volume":"15","author":"PL Mar","year":"2022","unstructured":"Mar\u00a0PL, Horbal\u00a0P, Chung\u00a0MK, Dukes\u00a0JW, Ezekowitz\u00a0M, Lakkireddy\u00a0D et\u00a0al (2022) Drug interactions affecting antiarrhythmic drug use. Circ Arrhythm Electrophysiol 15(5):e7955","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1745_CR24","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.amjcard.2023.01.035","volume":"192","author":"JA Reiffel","year":"2023","unstructured":"Reiffel\u00a0JA, Robinson\u00a0VM, Kowey\u00a0PR (2023) Perspective on antiarrhythmic drug combinations. Am J Cardiol 192:116\u2013123","journal-title":"Am J Cardiol"},{"issue":"8","key":"1745_CR25","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1093\/europace\/eup114","volume":"11","author":"YG Yap","year":"2009","unstructured":"Yap\u00a0YG, Behr\u00a0ER, Camm\u00a0AJ (2009) Drug-induced brugada syndrome. Europace 11(8):989\u2013994","journal-title":"Europace"},{"issue":"12","key":"1745_CR26","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.jacep.2022.11.001","volume":"8","author":"A Capucci","year":"2022","unstructured":"Capucci\u00a0A (2022) Pill in the pocket: a\u00a0safe and useful antiarrhythmic strategy. JACC Clin Electrophysiol 8(12):1521\u20131522","journal-title":"JACC Clin Electrophysiol"},{"issue":"4","key":"1745_CR27","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2165\/11599950-000000000-00000","volume":"35","author":"J Tamargo","year":"2012","unstructured":"Tamargo\u00a0J, Capucci\u00a0A, Mabo\u00a0P (2012) Safety of flecainide. Drug Saf 35(4):273\u2013289","journal-title":"Drug Saf"},{"issue":"3","key":"1745_CR28","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00399-017-0516-0","volume":"28","author":"W Haverkamp","year":"2017","unstructured":"Haverkamp\u00a0W, Israel\u00a0C, Parwani\u00a0A (2017) Klinische Besonderheiten der Therapie mit Amiodaron. Herzschrittmacherther Elektrophysiol 28(3):307\u2013316","journal-title":"Herzschrittmacherther Elektrophysiol"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-024-01745-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-024-01745-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-024-01745-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T07:05:11Z","timestamp":1721804711000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-024-01745-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,15]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["1745"],"URL":"https:\/\/doi.org\/10.1007\/s00108-024-01745-9","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"value":"2731-7080","type":"print"},{"value":"2731-7099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,15]]},"assertion":[{"value":"17 June 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"D.\u00a0Duncker erhielt moderate Vortragshonorare von Abbott, AstraZeneca, Biotronik, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, CVRx, Medtronic, Microport, Pfizer, Sanofi, Zoll. R.\u00a0Allgaier gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}